26 results on '"Klade, Christoph S."'
Search Results
2. Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study
3. Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51
4. Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients
5. Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects
6. IC51: a new investigational Japanese encephalitis vaccine
7. Analysis of the human cytomegalovirus pp65--directed T-cell response in healthy HLA-A2-positive individuals
8. Experimental discovery of T-cell epitopes: combining the best of classical and contemporary approaches
9. Pharmacokinetics of a Novel Anagrelide Extended-Release Formulation in Healthy Subjects: Food Intake and Comparison With a Reference Product
10. Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8 + T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses
11. Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination
12. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO®) induced neutralizing antibody titers
13. Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51
14. Evaluation of Serological Diagnostic Test Systems Assessing the Immune Response to Japanese Encephalitis Vaccination
15. Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine
16. Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C
17. Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41
18. Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis
19. Identification and characterization of 9D7, a novel human protein overexpressed in renal cell carcinoma
20. Identification of tumor antigens in renal cell carcinoma by serological proteome analysis
21. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO®) induced neutralizing antibody titers
22. Identification and characterization of 9D7, a novel human protein overexpressed in renal cell carcinoma.
23. Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8+ T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses.
24. Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51
25. Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8+ T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses.
26. Proteomics approaches towards antigen discovery and vaccine development.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.